The SV40 Late Protein VP4 Is a Viroporin that Forms Pores to Disrupt Membranes for Viral Release
Nonenveloped viruses are generally released by the timely lysis of the host cell by a poorly understood process. For the nonenveloped virus SV40, virions assemble in the nucleus and then must be released from the host cell without being encapsulated by cellular membranes. This process appears to involve the well-controlled insertion of viral proteins into host cellular membranes rendering them permeable to large molecules. VP4 is a newly identified SV40 gene product that is expressed at late times during the viral life cycle that corresponds to the time of cell lysis. To investigate the role of this late expressed protein in viral release, water-soluble VP4 was expressed and purified as a GST fusion protein from bacteria. Purified VP4 was found to efficiently bind biological membranes and support their disruption. VP4 perforated membranes by directly interacting with the membrane bilayer as demonstrated by flotation assays and the release of fluorescent markers encapsulated into large unilamellar vesicles or liposomes. The central hydrophobic domain of VP4 was essential for membrane binding and disruption. VP4 displayed a preference for membranes comprised of lipids that replicated the composition of the plasma membranes over that of nuclear membranes. Phosphatidylethanolamine, a lipid found at high levels in bacterial membranes, was inhibitory against the membrane perforation activity of VP4. The disruption of membranes by VP4 involved the formation of pores of ∼3 nm inner diameter in mammalian cells including permissive SV40 host cells. Altogether, these results support a central role of VP4 acting as a viroporin in the perforation of cellular membranes to trigger SV40 viral release.
Vyšlo v časopise:
The SV40 Late Protein VP4 Is a Viroporin that Forms Pores to Disrupt Membranes for Viral Release. PLoS Pathog 7(6): e32767. doi:10.1371/journal.ppat.1002116
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002116
Souhrn
Nonenveloped viruses are generally released by the timely lysis of the host cell by a poorly understood process. For the nonenveloped virus SV40, virions assemble in the nucleus and then must be released from the host cell without being encapsulated by cellular membranes. This process appears to involve the well-controlled insertion of viral proteins into host cellular membranes rendering them permeable to large molecules. VP4 is a newly identified SV40 gene product that is expressed at late times during the viral life cycle that corresponds to the time of cell lysis. To investigate the role of this late expressed protein in viral release, water-soluble VP4 was expressed and purified as a GST fusion protein from bacteria. Purified VP4 was found to efficiently bind biological membranes and support their disruption. VP4 perforated membranes by directly interacting with the membrane bilayer as demonstrated by flotation assays and the release of fluorescent markers encapsulated into large unilamellar vesicles or liposomes. The central hydrophobic domain of VP4 was essential for membrane binding and disruption. VP4 displayed a preference for membranes comprised of lipids that replicated the composition of the plasma membranes over that of nuclear membranes. Phosphatidylethanolamine, a lipid found at high levels in bacterial membranes, was inhibitory against the membrane perforation activity of VP4. The disruption of membranes by VP4 involved the formation of pores of ∼3 nm inner diameter in mammalian cells including permissive SV40 host cells. Altogether, these results support a central role of VP4 acting as a viroporin in the perforation of cellular membranes to trigger SV40 viral release.
Zdroje
1. ChenBJLambRA 2008 Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology 372 221 232
2. PornillosOGarrusJESundquistWI 2002 Mechanisms of enveloped RNA virus budding. Trends Cell Biol 12 569 579
3. HanZHartyRN 2004 The NS3 protein of bluetongue virus exhibits viroporin-like properties. J Biol Chem 279 43092 43097
4. AldabeRBarcoACarrascoL 1996 Membrane permeabilization by poliovirus proteins 2B and 2BC. J Biol Chem 271 23134 23137
5. FiersWContrerasRHaegemannGRogiersRVan de VoordeA 1978 Complete nucleotide sequence of SV40 DNA. Nature 273 113 120
6. ReddyVBThimmappayaBDharRSubramanianKNZainBS 1978 The genome of simian virus 40. Science 200 494 502
7. ColeCN 1996 Polyomavirinae: the viruses and their replication. FieldsBNKnipeDMHowleyPMChanockRMMelnickJL Fields virology. 3rd ed Philadelphia Lippincott-Raven 1997 2025
8. StehleTGamblinSJYanYHarrisonSC 1996 The structure of simian virus 40 refined at 3.1 A resolution. Structure 4 165 182
9. DanielsRSadowiczDHebertDN 2007 A Very Late Viral Protein Triggers the Lytic Release of SV40. PLoS Pathog 3 e98
10. BraunPLaBaerJ 2003 High throughput protein production for functional proteomics. Trends Biotechnol 21 383 388
11. KopitoRR 2000 Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10 524 530
12. BolenDW 2001 Protein stabilization by naturally occurring osmolytes. Methods Mol Biol 168 17 36
13. FisherMT 2006 Proline to the rescue. Proc Natl Acad Sci U S A 103 13265 13266
14. IgnatovaZGieraschLM 2006 Inhibition of protein aggregation in vitro and in vivo by a natural osmoprotectant. Proc Natl Acad Sci U S A 103 13357 13361
15. OjciusDMYoungJD 1991 Cytolytic pore-forming proteins and peptides: is there a common structural motif? Trends Biochem Sci 16 225 229
16. HeuckAPJohnsonAE 2005 Membrane Recognition and Pore Formation by Bacterial Pore-forming Toxins; TammL Wiley-VHC
17. ZhangLAgostoMAIvanovicTKingDSNibertML 2009 Requirements for the formation of membrane pores by the reovirus myristoylated micro1N peptide. J Virol 83 7004 7014
18. ClaphamDE 2007 Calcium signaling. Cell 131 1047 1058
19. von HeijneG 2006 Membrane-protein topology. Nat Rev Mol Cell Biol 7 909 918
20. WolfePBWicknerWGoodmanJM 1983 Sequence of the leader peptidase gene of Escherichia coli and the orientation of leader peptidase in the bacterial envelope. J Biol Chem 258 12073 12080
21. von HeijneG 1986 The distribution of positively charged residues in bacterial inner membrane proteins correlates with the transmembrane topology. EMBO J 5 3021 3027
22. DanielsRRusanNMWadsworthPHebertDN 2006 SV40 VP2 and VP3 Insertion into ER Membranes Is Controlled by the Capsid Protein VP1: Implications for DNA Translocation out of the ER. Mol Cell 24 955 966
23. InabaMYawataAKoshinoISatoKTakeuchiM 1996 Defective anion transport and marked spherocytosis with membrane instability caused by hereditary total deficiency of red cell band 3 in cattle due to a nonsense mutation. J Clin Invest 97 1804 1817
24. HeuckAPTwetenRKJohnsonAE 2003 Assembly and topography of the prepore complex in cholesterol-dependent cytolysins. J Biol Chem 278 31218 31225
25. van MeerGVoelkerDRFeigensonGW 2008 Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 9 112 124
26. NeitchevaTPeevaD 1995 Phospholipid composition, phospholipase A2 and sphingomyelinase activities in rat liver nuclear membrane and matrix. Int J Biochem Cell Biol 27 995 1001
27. JainMKWagnerRC 1980 Introduction to Biological Membranes. New York Wiley
28. ScherrerRGerhardtP 1971 Molecular sieving by the Bacillus megaterium cell wall and protoplast. J Bacteriol 107 718 735
29. TaoMConwayR 1982 Membrane Abnormalities and Disease TaoM Boca Raton, FL CRC Press
30. MatsuzakiKSugishitaKIshibeNUehaMNakataS 1998 Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry 37 11856 11863
31. LeeMTHungWCChenFYHuangHW 2005 Many-body effect of antimicrobial peptides: on the correlation between lipid's spontaneous curvature and pore formation. Biophys J 89 4006 4016
32. BhakdiSBayleyHValevaAWalevIWalkerB 1996 Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins. Arch Microbiol 165 73 79
33. GonzalezMECarrascoL 2003 Viroporins. FEBS Lett 552 28 34
34. BrogdenKA 2005 Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3 238 250
35. YangLHarrounTAWeissTMDingLHuangHW 2001 Barrel-stave model or toroidal model? A case study on melittin pores. Biophys J 81 1475 1485
36. NievaJLAgirreANirSCarrascoL 2003 Mechanisms of membrane permeabilization by picornavirus 2B viroporin. FEBS Lett 552 68 73
37. SuzukiTOrbaYOkadaYSundenYKimuraT 2010 The human polyoma JC virus agnoprotein acts as a viroporin. PLoS Pathog 6 e1000801
38. KartenbeckJStukenbrokHHeleniusA 1989 Endocytosis of simian virus 40 into the endoplasmic reticulum. J Cell Biol 109 2721 2729
39. NorkinLCAndersonHAWolfromSAOppenheimA 2002 Caveolar endocytosis of simian virus 40 is followed by brefeldin A-sensitive transport to the endoplasmic reticulum, where the virus disassembles. J Virol 76 5156 5166
40. PelkmansLKartenbeckJHeleniusA 2001 Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 3 473 483
41. RichardsAAStangEPepperkokRPartonRG 2002 Inhibitors of COP-mediated transport and cholera toxin action inhibit simian virus 40 infection. Mol Biol Cell 13 1750 1764
42. TsaiB 2007 Penetration of nonenveloped viruses into the cytoplasm. Annu Rev Cell Dev Biol 23 23 43
43. MarshMHeleniusA 2006 Virus entry: open sesame. Cell 124 729 740
44. DanielsRRusanNMWilbuerAKNorkinLCWadsworthP 2006 Simian virus 40 late proteins possess lytic properties that render them capable of permeabilizing cellular membranes. J Virol 80 6575 6587
45. Rainey-BargerEKMagnusonBTsaiB 2007 A chaperone-activated non-enveloped virus perforates the physiologically relevant ER membrane. J Virol 81 12996 13004
46. JaysingheSHristovaKWimleyWSniderCWhiteSH 2010 Membrane Protein Explorer. http://blanco.biomol.uci.edu/mpex/
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 6
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- High Affinity Nanobodies against the VSG Are Potent Trypanolytic Agents that Block Endocytosis
- Structural and Mechanistic Studies of Measles Virus Illuminate Paramyxovirus Entry
- Sporangiospore Size Dimorphism Is Linked to Virulence of
- The Binding of Triclosan to SmeT, the Repressor of the Multidrug Efflux Pump SmeDEF, Induces Antibiotic Resistance in